Medicenna Therapeutics Corp.
MDNA.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 37.79% | 26.54% | 18.61% | 16.40% | -49.49% |
| Total Receivables | 118.12% | 224.97% | 386.30% | 38.11% | 36.03% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -35.33% | -48.55% | -54.46% | 4.69% | -51.90% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 39.12% | 26.59% | 18.21% | 16.59% | -47.61% |
|
|
|||||
| Total Current Assets | 39.12% | 26.59% | 18.21% | 16.59% | -47.61% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -14.01% | -16.17% | -8.26% | -11.26% | -6.65% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 39.74% | 27.17% | 18.85% | 16.62% | -47.54% |
|
|
|||||
| Total Accounts Payable | 22.93% | -57.14% | -46.12% | 5.76% | 27.91% |
| Total Accrued Expenses | 100.19% | -- | -- | -- | -63.70% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 661.39% | -- |
| Total Other Current Liabilities | -- | -- | -- | 661.39% | -- |
| Total Current Liabilities | 45.93% | -37.20% | -22.33% | 215.37% | -58.90% |
|
|
|||||
| Total Current Liabilities | 45.93% | -37.20% | -22.33% | 215.37% | -58.90% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -59.76% | -- | 1,516.94% | -- | -- |
| Total Liabilities | -37.25% | 192.59% | 199.45% | 215.37% | 100.17% |
|
|
|||||
| Common Stock & APIC | 7.62% | 4.90% | 12.32% | 7.58% | 1.01% |
| Retained Earnings | -4.66% | -18.46% | -30.64% | -27.03% | -31.34% |
| Treasury Stock & Other | 48,770.00% | 22,546.20% | 32,643.24% | 25,755.56% | -66.75% |
| Total Common Equity | 246.55% | -14.02% | -14.33% | -17.70% | -82.41% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 246.55% | -14.02% | -14.33% | -17.70% | -82.41% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 246.55% | -14.02% | -14.33% | -17.70% | -82.41% |
|
|
|||||